SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small Cell Lung Cancer — A Multicentre Single-Arm Phase II Trial
暂无分享，去创建一个
S. Peters | C. Britschgi | D. Betticher | M. Joerger | R. Cathomas | P. Bohanes | S. Rothschild | D. Lardinois | W. Weder | S. Savic Prince | A. Zippelius | A. Ochsenbein | M. Pless | P. Froesch | N. Mach | M. Früh | M. Buess | W. Janthur | Michel Gonzalez | S. S. Prince | C. Rusterholz | M. Mark | H. Gelpke | L. Mauti | E. Eboulet | A. Bettini | C. Waibel | G. Godar | E. I. Eboulet | Swiss Group for Clinical Cancer Res Group